Medical Cannabis Market With Latest Research Report
Medical cannabis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 82.19 billion by 2027 growing at a CAGR of 20.25% in the above-mentioned forecast period. Increasing awareness about the advantages of cannabis is expected to create new opportunity for the market.
Focus of the report:
The report focuses to provide all the insights of the Global Medical Cannabis Market along with all CAGR values and the market shares analysis of all the players in the market. The report is a vital piece of information on the market which explains all the competitive landscape and all the segments in the market while analyzing and forecasting the Global Medical Cannabis Market for the coming years. The report also provides all details in terms of recent developments in the market and all the manufacturers.
The major players covered in the medical cannabis market report are Canopy Growth Corporation, GW Pharmaceuticals plc., Aurora Cannabis., Aphria Medical Cannabis, MedReleaf Corp, CanniMed Ltd, United Cannabis., The Peace Naturals Project Inc., Medical Marijuana, Inc, BOL Pharma, Cresco Labs, Cresco Labs, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa(MEA) and South America separately. DBMR analystsunderstand competitive strengths and provide competitive analysis for each competitor separately.
Less side effects of the cannabis as compared to the other treatment options is expected to enhance the market growth. Some of the other factors such as rising ageing population, increasing clinical trials and research development activities, rising disposable income, and rising healthcare spending will drive the medical cannabis market in the forecast period of 2020 to 2027.
Global Medical Cannabis Market,By Species (Cannabis Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others), Application (Pharmaceutical Industry, Research and Development Centers, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027
Global Medical Cannabis Market Scope and Market Size
Medical cannabis market is segmented of the basis of species, derivatives, application and route of administration. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid.
- Derivatives segment of the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC), and others.
- The application segment of the medical cannabis market is divided into pharmaceutical industry, research and development centers and others.
- Based on route of administration, the medical cannabis market is bifurcated into oral solutions and capsules, smoking, vaporizers, topicals and others.
Medical Cannabis Market Country Level Analysis
Medical cannabis market is analysed and market size insights and trends are provided by country, species, derivatives, application and route of administration as referenced above.
The countries covered in the medical cannabis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
The country section of the medical cannabis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Medical cannabis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for medical cannabis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medical cannabis market. The data is available for historic period 2010 to 2018.
Credit to: Data Bridge